
Ecosprin Gold 20 mg Capsule
Salt Composition: Aspirin (75mg) + Atorvastatin (20mg) + Clopidogrel (75mg)
Expiry Date: 01/2028
Inclusive of all taxes
15 Capsule
About The Product
Prevents clotting + cholesterol management
Indication
Prevent Blood Clots
Dosage And Administration
- Ecosprin Gold 20mg Capsule is taken orally.
- Tablet is swallowed as it is with the help of water.
- It can be taken after or before food consumption (Prefer After Food).
- Avoid crushing, chewing, breaking or biting of tablet to maintain its efficacy.
- In general,Ecosprin Gold 20mg Capsule dosage in just one tablet at same time every day.
- For more personalized assistance and exact dosage, talk to your doctor about the same.
Mechanism Of Action
Ecosprin Gold 20mg Capsule functions in three ways: atorvastatin (20mg) competitively inhibits HMG-CoA reductase in the liver to reduce cholesterol biosynthesis, lowering LDL/triglycerides and stabilising plaques, while aspirin (75mg) irreversibly inhibits platelet COX-1 via acetylation to block thromboxane A2 synthesis and prevent aggregation/clot formation.Moreover, 75 mg of Clopidogrel is a Prodrug is transformed into an active metabolite that binds P2Y12 receptors permanently, preventing ADP-induced platelet activation and aggregation and working in concert with aspirin.
Faqs
Ecosprin Gold 20mg Capsule used to heart attacks, strokes, and cardiovascular events prescribed mainly for high-risk patients with dyslipidemia, atherosclerosis, post-heart attack/stroke prevention, angina, or peripheral artery disease.
References
• Wang, T. H., Bhatt, D.
L., & Topol, E. J.
(2006). Aspirin and clopidogrel resistance: an emerging clinical entity.
European heart journal, 27(6), 647-654. • Cattaneo, M. (2004).
Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance. Arteriosclerosis, thrombosis, and vascular biology, 24(11), 1980-1987. • Gorelick, P.
B., Born, G. V., D’Agostino, R.
B., Hanley Jr, D. F., Moye, L., & Pepine, C.
J. (1999).
Therapeutic benefit: aspirin revisited in light of the introduction of clopidogrel. Stroke, 30(8), 1716-1721. • Savi, P., Nurden,P., Nurden, A.
T., Levy-Toledano, S., & Herbert, J. M.
(1998). Clopidogrel: a review of its mechanism of action.
Platelets, 9(3-4), 251-255.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
